Response to: 'Comparing the immunogenicity of the etanercept biosimilar SB4 with the innovator etanercept: another consideration’ by Marshall et al.

Emery, P, Vencovský, J, Ghil, J et al. (1 more author) (2016) Response to: 'Comparing the immunogenicity of the etanercept biosimilar SB4 with the innovator etanercept: another consideration’ by Marshall et al. Annals of the Rheumatic Diseases, 75 (7). e38-e38. ISSN 0003-4967

Metadata

Authors/Creators:
  • Emery, P
  • Vencovský, J
  • Ghil, J
  • Won Kang, J
Copyright, Publisher and Additional Information: This is an author produced version of a paper published in Annals of the Rheumatic Diseases. Uploaded in accordance with the publisher's self-archiving policy.
Dates:
  • Accepted: 31 March 2016
  • Published (online): 4 May 2016
  • Published: July 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) > Clinical Musculoskeletal Medicine (LIRMM) (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 06 May 2016 14:21
Last Modified: 26 Oct 2016 08:52
Published Version: http://dx.doi.org/10.1136/annrheumdis-2016-209517
Status: Published
Publisher: BMJ Publishing Group
Identification Number: https://doi.org/10.1136/annrheumdis-2016-209517

Export

Statistics


CORE (COnnecting REpositories)